ASTRO commends new prior authorization legislation June 7, 2019 -- The American Society for Radiation Oncology (ASTRO) is lauding bipartisan federal legislation that would curb restrictive prior authorization practices that delay patient access to critical cancer treatments.
UPenn gets $12M grant for new cancer therapy center June 3, 2019 -- The University of Pennsylvania (UPenn) has received a grant for $12 million from The Mark Foundation for Cancer Research to establish a new research center focused on investigating potential connections between novel forms of radiation therapy and immunotherapy.
Lantheus inks radiopharma deal with NanoMab May 31, 2019 -- Lantheus Holdings, the parent company of Lantheus Medical Imaging, has entered into a strategic collaboration and license agreement with biopharmaceutical firm NanoMab Technology to develop next-generation radiopharmaceuticals for immuno-oncology therapies.
3D printing customizes brachytherapy for cervical cancer May 23, 2019 -- Researchers from the Netherlands have created individually tailored 3D-printed brachytherapy applicators based on the MRI scans of patients with cervical cancer, potentially improving access to tumors during treatment, according to an article published online recently in 3D Printing in Medicine. Discuss
RefleXion files 510(k), opens manufacturing facility May 23, 2019 -- Radiation therapy equipment developer RefleXion Medical has filed a 510(k) application with the U.S. Food and Drug Administration for its biology-guided radiotherapy system. The firm also opened a new 50,000-sq-ft manufacturing facility in Hayward, CA.
How does chemo during pregnancy affect child development? May 21, 2019 -- Chemotherapy performed on women during pregnancy could adversely affect long-term cortical development in their children's brains, according to a preliminary study presented last week at the International Society for Magnetic Resonance in Medicine annual meeting in Montreal. Discuss
Varian to acquire cancer treatment provider May 21, 2019 -- Radiation therapy firm Varian Medical Systems said it has entered into a definitive agreement to acquire Cancer Treatment Services International for $283 million.
Shine signs Czech license agreement May 16, 2019 -- Medical isotope firm Shine Medical Technologies has signed an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague).
Radiation therapy (RT) could be more effective in African-American men with prostate cancer than previously realized, according to data presented at the American Society for Radiation Oncology (ASTRO) annual meeting. Read more